SCRUTINIZING CKD ASSOCIATED SECONDARY HYPERPARATHYROID DOSSIER

AYESHA HABEEB; HAFSA SANIA; MARYAM SHAIK; UMAIR WAHEDI; SYED AMER

Volume : VII, Issue : IV, April - 2018

SCRUTINIZING CKD ASSOCIATED SECONDARY HYPERPARATHYROID DOSSIER

Ayesha Habeeb, Hafsa Sania, Maryam Shaik, Umair Wahedi, Syed Amer

Abstract :

The kidney:improving global outcome guideline recommended that screening of renal hyperparathyroidism(rHPT) should be considered during CKD stage 3.Renal hyperparathyroidism (rHPT)or secondary hyperparathyroidism is a common complication of chronic kidney disease characterized by elevated parathyroid hormone levels secondary to derangements in the homeostasis of calcium, phosphate, and vitamin D.A 55 yearsold male patient presented with swelling in the neck associated with difficulty in speaking and sleeping, Reduced appetite(since 15days),Anasarca(since 15days),Shortness of eath(since 15days),Nausea, Vomiting(1 episode before hospitalization), Associated with 2 cm thyroid nodule and with comorbidities (Chronic Kidney Disease(CKD) , Hypertension(HTN) and Cardiovascular Disease(CVD).Patients with rHPT have high risk of developing cardiovascular and bone diseases, This case study shows that there is a need in improving therapeutic strategies and Patient�s medical compliance, which makes a critical component in improving outcome and patients quality of life.